Audicin is expanding its brainwave-based recovery technology across consumer and enterprise use cases, including secure environments, while introducing an SDK that enables real-time integration into third-party platforms.
Audicin, a Finland-based neurotechnology company developing real-time nervous system regulation tools, has raised $1.9 million in funding. The round includes private investment, follow-on backing from Petteri Lahtela and Virpi Tuomivaara, as well as support from Business Finland through its Deep Tech Accelerator programme. The funding brings the company’s total capital raised to approximately $3 million.
The company develops solutions based on brainwave entrainment, auditory engineering, and music neuroscience to support focus, stress recovery, productivity, and sleep. Its technology delivers real-time background listening sessions that adapt to physiological signals, enabling continuous nervous system regulation throughout the day.
A core component of the offering is Audicin for Apps, an SDK designed to integrate real-time regulation protocols directly into digital health, performance, and consumer platforms. The SDK operates passively – triggered by biometric data, time of day, or in-app events—and integrates with wearable devices such as Oura, Apple Watch, Garmin, and Whoop, without requiring additional hardware.
In parallel, the company is advancing a standalone, offline Sleep Headband designed for use in environments where mobile devices are restricted, including healthcare and defence settings. The device delivers pre-configured recovery programmes based on low-frequency brainwave protocols associated with deep sleep.
According to co-founder and CEO Laura Avonius, the company is focused on embedding nervous system support into everyday environments, enabling real-time regulation without requiring dedicated user attention, and expanding into contexts where maintaining recovery and performance is more challenging.
Audicin is seeing early commercial traction across sectors, including defence, performance, and wellness, with a growing pipeline of enterprise opportunities and increasing user engagement following recent product updates.
The funding will support the commercialisation of Audicin’s core products, including its mobile application, Sleep Headband, and Audicin for Apps, as well as further product development and expansion into new use cases and markets.